Oct 29, 2018
Avanish Vellanki, Co-Founder and CEO, Rain Therapeutics talks about developing targeted therapies for patients across a range of cancers. Their lead program tarloxotinib is currently being developed for non-small cell lung cancer patients with EGFR/Exon 20 mutations. Avanish fills us in on what makes tarloxotinib...
Oct 25, 2018
Joanne Jarrett MD is a retired family physician, blogger, mom, wife and entrepreneur and talks with me about her provocative blog post Three Ways We May Be Teaching Our Kids To Be Liars. Joanne points out that dishonesty is a misguided short-cut when attempting to avoid hurt feelings and that kids need to learn to...
Oct 17, 2018
Gilead Raday, COO, RedHill Biopharma discusses development of the next generation of effective therapies for gastrointestinal disorders and cancer that affect millions of people worldwide. This includes treatment for H. pylori infections which can cause ulcers and gastric cancer, the first-ever therapy for Crohn's...
Oct 11, 2018
Vik Panda, VP Marketing, Adherium talks about their Hailie sensors which allow patients and doctors to track use of inhalers and help manage chronic respiratory illnesses like asthma and COPD. With a smart case for the inhaler and a mobile app, patients get alerts, nudges and data to help them adhere to a plan to keep...